🔎 Trials Near Me

መነሻ › አኩት ማይሎይድ ሊውኬሚያ › New York › New York City

በNew York City፣ NY ለአኩት ማይሎይድ ሊውኬሚያ የሚደረጉ ክሊኒካዊ ጥናቶች

ለአኩት ማይሎይድ ሊውኬሚያ የሚደረጉ 51 ጥናቶች በNew York City እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።

Official study text (English)

ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Mount Sinai Hospital, New York
  • Memorial Sloan Kettering Cancer Center, New York
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ5 ኦክቶ 2026 · NCT05564390

A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Memorial Sloan Kettering Cancer Center, New York
እስከ እድሜ 21 · ሁሉም ጾታዎች · የተሻሻለው በ5 ኦክቶ 2026 · NCT07012044

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናትጤናማ ተሳታዮች ይቀበላሉ
  • NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
እድሜ ከ40 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT05334069

Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Memorial Sloan Kettering Cancer Center, New York
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ1 ኦክቶ 2026 · NCT06484062

A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Memorial Sloan Kettering Cancer Center, New York
እድሜ ከ12 እስከ 78 · ሁሉም ጾታዎች · የተሻሻለው በ29 ሴፕቴ 2026 · NCT03802695

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Mount Sinai Hospital, New York
  • Memorial Sloan Kettering Cancer Center, New York
እድሜ ከ18 እስከ 59 · ሁሉም ጾታዎች · የተሻሻለው በ28 ሴፕቴ 2026 · NCT05554393

A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Memorial Sloan Kettering Cancer Center, New York
  • New York Presbyterian - Weill Cornell, New York
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT06852222

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Memorial Sloan Kettering Cancer Center, New York
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT06672146

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Mount Sinai Hospital, New York
  • Memorial Sloan Kettering Cancer Center, New York
እድሜ ከ18 እስከ 59 · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT05554406

A Study of CRD3874-SI in People With Leukemia

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT07661095

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Memorial Sloan Kettering Cancer Center, New York
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT06317649

A Multi-Site Break Through Cancer Trial: Phase II Study Investigating Dual Inhibition of BCL2 and Menin in AML MRD Using the Combination of Venetoclax and Revumenib

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Memorial Sloan Kettering Cancer Center, New York
እድሜ 12 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ18 ሴፕቴ 2026 · NCT06284486

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
  • NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
  • Memorial Sloan Kettering Cancer Center, New York
  • እና 1 ተጨማሪ
6 Months – 21 Years · ሁሉም ጾታዎች · የተሻሻለው በ17 ሴፕቴ 2026 · NCT04293562

A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Montefiore Medical Center, New York
30 Days · ሁሉም ጾታዎች · የተሻሻለው በ16 ሴፕቴ 2026 · NCT04065399

Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Weill Cornell, New York
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ16 ሴፕቴ 2026 · NCT06824168

Cord Blood Transplant in Adults With Blood Cancers

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Memorial Sloan Kettering Cancer Center, New York
እድሜ ከ21 እስከ 65 · ሁሉም ጾታዎች · የተሻሻለው በ11 ሴፕቴ 2026 · NCT05884333

Eganelisib as Monotherapy and in Combination With Cytarabine in Relapsed/Refractory AML

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Memorial Sloan Kettering Cancer Center, New York
  • Memorial Sloan Kettering Cancer Center, New York
  • Montefiore Medical Center, New York
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ኦገስ 2026 · NCT06533761

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
  • Memorial Sloan Kettering Cancer Center, New York
እስከ እድሜ 22 · ሁሉም ጾታዎች · የተሻሻለው በ25 ኦገስ 2026 · NCT04726241

Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Columbia University Irving Medical Center, New York
  • Memorial Sloan Kettering Cancer Center - New York, New York
29 Days – 21 Years · ሁሉም ጾታዎች · የተሻሻለው በ24 ኦገስ 2026 · NCT05183035

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Icahn School of Medicine at Mount Sinai, New York
  • Columbia University, New York
  • Weill Cornell Medical Center, New York
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ20 ኦገስ 2026 · NCT07007312

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Memorial Sloan Kettering Cancer Center, New York
  • Weill Cornell Medical College-NY Presbyterian Hospital, New York
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ20 ኦገስ 2026 · NCT06001788

ICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid Malignancies

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • NYU Langone Health, New York
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ18 ኦገስ 2026 · NCT06656494

Olutasidenib DDI Study in Patients With IDH1 Mutation Positive Malignancies

ተሳታዮችን በመፈለግ ላይደረጃ 4
  • New York Presbyterian Hospital-Columbia University Medical Center, New York
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ11 ኦገስ 2026 · NCT07486713

Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Memorial Sloan- Kettering Cancer Center, New York
እድሜ ከ1 እስከ 30 · ሁሉም ጾታዎች · የተሻሻለው በ3 ኦገስ 2026 · NCT06177067

Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Research Site, New York
እድሜ 16 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ20 ጁላይ 2026 · NCT07155226

A Study of the Combination of Ivosidenib, Azacitidine, and Venetoclax Followed by Ivosidenib Alone in People With Acute Myeloid Leukemia

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
እድሜ 60 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ17 ጁላይ 2026 · NCT07392242

Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Weill Cornell Medicine - New York Presbyterian Hospital, New York
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ7 ጁላይ 2026 · NCT07216443

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • New York University Langone Medical Center, New York
  • New York Presbyterian Hospital at Cornell, New York
  • Mount Sinai Medical Center - New York, New York
  • እና 3 ተጨማሪ
ለሁሉም እድሜ · ሁሉም ጾታዎች · የተሻሻለው በ6 ጁላይ 2026 · NCT01351545

A Study of Revumenib and Mezigdomide in People With Leukemia

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
እድሜ 12 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ጁን 2026 · NCT07356154

A Study of CD371-YSNVZIL-18 CAR T Cells in People With Acute Myeloid Leukemia

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Memorial Sloan Kettering Cancer Center (All protocol activites), New York
እድሜ 1 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ጁን 2026 · NCT06017258

A Study of Gilteritinib in Combination With Ivosidenib or Enasidenib in People With Acute Myeloid Leukemia (AML)

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ጁን 2026 · NCT05756777

A Study of Natural Killer Cells in Combination With Atezolizumab in People With Acute Myelogenous Leukemia

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Memorial Sloan Kettering Cancer Center, New York
እድሜ ከ18 እስከ 70 · ሁሉም ጾታዎች · የተሻሻለው በ17 ጁን 2026 · NCT07011004

BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • New York Medicine-New York-Presbyterian Hospital, New York
  • Montefiore Medical Center - Montefiore Hospital, New York
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ15 ጁን 2026 · NCT05768932

Cord Blood Transplantation in Children and Young Adults With Blood Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
እስከ እድሜ 26 · ሁሉም ጾታዎች · የተሻሻለው በ14 ሜይ 2026 · NCT07566377

A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)

ተሳታዮችን በመፈለግ ላይደረጃ 2/3
  • Perlmutter Cancer Center - 34th Street, New York
  • Icahn School of Medicine at Mount Sinai, New York
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ30 ኤፕሪ 2026 · NCT04256317

Imetelstat Combinations in Relapsed AML

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Icahn School of Medicine at Mount Sinai, New York
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ኤፕሪ 2026 · NCT07320235

A Study of GLB-001 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher Risk Myelodysplastic Syndromes

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Icahn School of Medicine at Mount Sinai, New York
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ13 ኤፕሪ 2026 · NCT06146257

Safety and Proof-of-Concept Study of RPT1G in Adults With Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndromes

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Memorial Sloan Kettering Cancer Center, New York
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ማርች 2026 · NCT07107126

A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Memorial Sloan Kettering, New York
እድሜ ከ18 እስከ 66 · ሁሉም ጾታዎች · የተሻሻለው በ17 ማርች 2026 · NCT06859424

A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Memorial Sloan Kettering Cancer Center, New York
እድሜ 12 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ16 ማርች 2026 · NCT06994676

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • New York - Presbyterian / Weill Cornell Medicine, New York
  • Mount Sinai - Ruttenberg Treatment Center, New York
  • Columbia University Medical Center, New York
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ13 ማርች 2026 · NCT05735184

Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Memorial Sloan Kettering Cancer Center, New York
እስከ እድሜ 21 · ሁሉም ጾታዎች · የተሻሻለው በ13 ማርች 2026 · NCT04644016

A Study of ADCLEC.syn1 in People With Acute Myeloid Leukemia

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Memorial Sloan Kettering Cancer Center, New York
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ10 ማርች 2026 · NCT05748197

A Study of Azacitidine and Venetoclax in People With Acute Myeloid Leukemia (AML)

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ24 ፌብሩ 2026 · NCT06773208

CLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • New York University, New York
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ16 ጃንዩ 2026 · NCT05143996

Pharmacokinetic and Safety Study of MRX-2843 in Adolescents and Adults With Relapsed/Refractory AML, ALL, or MPAL

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Memorial Sloan Kettering Cancer Center, New York
እድሜ 12 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ8 ጃንዩ 2026 · NCT04872478

A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Memorial Sloan Kettering Cancer Center, New York
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ24 ሴፕቴ 2025 · NCT06501196

Study of REM-422 in Patients With AML or Higher Risk MDS

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Memorial Sloan Kettering, New York
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ23 ኤፕሪ 2025 · NCT06297941

A Clinical Trial of BP1002 in Patients With Refractory/Relapsed Acute Myeloid Leukemia (AML)

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Weill Cornell Medical College - NewYork-Presbyterian Hospital, New York
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ10 ማርች 2025 · NCT05190471

Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Laura & Isaac Pe lmutter Cancer Center at NYU Langone Health, New York
  • Weill Cornell Medical College - New York - Presbyterian Hospital, New York
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ7 ማርች 2025 · NCT02781883

A Study of BTX-A51 in People With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Memorial Sloan-Kettering Cancer Center, New York
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ20 ማርች 2024 · NCT04243785

በሌሎች ከተሞች ለአኩት ማይሎይድ ሊውኬሚያ የሚደረጉ ጥናቶች

በNew York City ውስጥ ያሉ ሌሎች ጥናቶች

ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ6 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።